- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about RXRX
Recent news which mentions RXRX
From InvestorPlace
3 Stocks to Buy for Their Proximity to Nvidia
November 08, 2023
From InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
From Benzinga
The 7 Best Cathie Wood Stocks to Buy Now: November Edition
November 01, 2023
From InvestorPlace
2 Reasons to Buy Recursion Pharmaceuticals, and 1 Reason to Sell
October 31, 2023
Tickers
RXRX
From Motley Fool
3 Extra-Speculative Stocks That Could Make You Very, Very Rich
October 26, 2023
From InvestorPlace
2 Risky Stocks With Massive Potential
October 17, 2023
From Motley Fool
From Motley Fool
2 Cathie Wood Stocks I'm Bullish On
October 05, 2023
From Motley Fool
2 AI Stocks That Aren't Worth the Hype
October 04, 2023
From Motley Fool
Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?
October 02, 2023
From Benzinga
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
From Motley Fool
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
September 22, 2023
From InvestorPlace
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
September 22, 2023
From Motley Fool
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
September 15, 2023
From Motley Fool
3 AI Drug Discovery Stocks to Watch
September 15, 2023
From Motley Fool
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Where Will Recursion Pharmaceuticals Be in 3 Years?
September 11, 2023
Tickers
RXRX
From Motley Fool
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
From MarketWatch
From Motley Fool
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
September 05, 2023
From InvestorPlace
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again
August 30, 2023
From Motley Fool
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
August 25, 2023
From Motley Fool
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
August 24, 2023
From Benzinga
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
August 24, 2023
From Motley Fool
3 Clever Tricks to Find Winning Biotech Stocks
August 24, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.